Xeno Biosciences
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase 1b Study to Evaluate the Safety of XEN-101 (NCT06417697) | Xeno Biosciences | 2024-05-24 |
| A Phase 1 Study to Evaluate Safety and Tolerability of Single and Multiple Ascending Doses of XEN-101 (NCT05667129) | Xeno Biosciences | 2022-12-01 |
Track Xeno Biosciences automatically
Every clearance here is in the API, with alerts when new ones post.